Lupron Prostate Cancer
explanatory Essay
573 words
Glands in the body produce hormones which act as chemical signals. The hormones travel through the bloodstream and affect how the cells and tissues act in the body. Androgens are male sex hormones which aid in the development and maintenance of traits in a man. The most common androgens in a male are testosterone and dihydrotestosterone (DHT). Testosterone is mainly released by the testicles; however, small amounts of the hormone are produced by the adrenal glands. Male hormones, especially testosterone, are responsible for fueling prostate cancer; the hormones accelerate the growth of the cancerous cells. If a man has the ailment, the physician may prescribe Lupron for prostate cancer.
Lupron and prostate cancer
Before getting to understand how Lupron depot for prostate cancer works, let’s find out how the hormones support or stimulate the growth of prostate cancer cells. A prostate is a gland in the reproductive system of a man and its main function is to produce semen. For the normal growth and function of prostate gland, androgens are important. Prostate cancer cells and non-cancerous cells can’t grow and spread in the absence of this crucial hormone; the hormone fuels cancer by attaching to as well as activating the protein (androgen receptor)
…show more content…
In this essay, the author
- Explains that androgens are male sex hormones which aid in the development and maintenance of traits in a man.
- Explains how the hormones support or stimulate the growth of prostate cancer cells. lupron fuels cancer by attaching to and activating the protein (androgen receptor) expressed in the cancerous cells
- Explains that in the early stages of prostate cancer, the ailment requires elevated levels of androgens to spread. lupron therapy is effective if cancer has spread outside the prostate, also in patients who want to shrink the growth in readiness for surgery.
- Explains that lupron is effective in prostate cancer management. it belongs to a class of medications known as lhrh agonists.
- Explains that lhrh triggers the pituitary gland to produce lh (luteinizing hormone), triggering testosterone production, causing testosterone flare.
What does Lupron do for prostate cancer? Lupron is a prescription drug which is used for a number of functions. It belongs to a class of medications known as LHRH (luteinizing –hormone releasing hormone) Agonists. LHRH is a vital hormone released into your body before testosterone production. Blocking the production of LHRH by using Lupron injection for prostate cancer is an example of a therapy known as androgen suppression or androgen deprivation. Lupron injection hinders the release of luteinizing hormone; it binds to the LHRH receptors on your pituitary gland so interfering with the production of testosterone. For an elaborate explanation, continue
Related
- comparative
- explanatory
- opinion
- analytical
- Prostate Cancercomparative essayProstate Cancer The prostate gland is an egg-sized organ that rings the male urethra. The secretions of the prostate give nutrients to the semen. Prostate cancer is the most commonly diagnosed cancer and the second most common cause of cancer death in men. (Ernstoff,Heaney,Peschel,1998,pviii) Like all cancers, prostate cancer is an uncontrolled cell production in a particular organ or area of the body.
In this essay, the author
- Explains that prostate cancer is the most commonly diagnosed cancer and the second most common cause of cancer death in men.
- Explains that men are off their feet for two to three weeks, unless radiation therapy is needed. the catheter is removed and the bladder is deflated.
- Explains that american men are not aware of the risk factors of prostate cancer and advises that testing for the cancer should begin at the age of thirty.
- Concludes that prostate cancer is a leading disease in the death of males. it's important that men get annual tests to catch the cancer in its early forms.
- Cites the american cancer society's cancer facts and figures: prostate cancer.
- Cites blackwell science, inc., national prostate cancer coalition, and the american cancer society.
- Summarizes the findings of the national prostate cancer coalition.
1008 wordsRead More - Essay On Prostate Cancerexplanatory essayProstate Cancer What is Prostate cancer? Prostate cancer affects the tissue of the prostate, a gland of the male reproductive system found below the bladder and in front of the rectum. The cancerous cells growing in the prostate do not destroy this gland, but rather form masses of abnormal cells also known as a tumor. Typically, prostate cancer grow to a detectable size over a long period of time and an even longer time to metastasize.
In this essay, the author
- Explains prostate cancer affects the tissue of the prostate, a gland of male reproductive system located below the bladder and in front of rectum.
- Explains that not everyone will have or even show signs of prostate cancer. many of the cases are first detected during a doctor’s check-up.
- Explains that the most widely used staging system for prostate cancer is the american joint committee on cancer (ajcc) tnm system.
- Explains that men who eat red meat and high-fat dairy are at a slightly higher risk for prostate cancer. reducing consumption of these foods may reduce the risk.
- Explains that 90% of prostate cancers are classified as acinar adenocarcinoma, including atrophic, foamy, colloid, and signet ring carcinomas.
- Explains that digital rectal exams, blood tests, ultrasound, and mri scans can detect prostate cancer.
- Explains that surgery for prostate cancer is a common treatment choice if the cancer has not metastasized. external radiation therapy uses high-energy rays or particles to kill cancer cells.
- Explains that 6 in 10 cases of prostate cancer are diagnosed in men over 65 years old. ethnicity: african american men are 2.5 times more likely to develop the disease than caucasian men.
1042 wordsRead More - Proper Prostrate Cancer Treatmentexplanatory essayBeing diagnosed with cancer has always been taken as a death sentence by a majority of the population. This can partly be contributed by the fact that most people do not understand clearly what cancer is. The way most reporters and some journalist have reviewed information relating to prostate cancer has been hazardous.
In this essay, the author
- Explains cryosurgery, which involves freezing and thawing prostate tissue to destroy it, is not common and its success rate is yet to be determined.
- Explains that bowsher, winsor, and adam carter. challenges in prostate cancer.
- Explains that cancer has always been taken as a death sentence by the majority of the population. prostate cancer is the abnormal growth of cells in the prostate gland.
- Explains that men of african american descent and those with a prostate cancer family history are considered to be high-risk.
- Explains that acute kidney failure and deep bone pain are signs of prostate cancer. spinal cord compression is one of the positive indicators of cancer and should always be treated as an emergency.
- Explains that the digital rectal exam cannot detect all types of prostate cancer — a biopsy is performed by an urologist. the easiest and most effective treatment options are surgery, radiation therapy, and active surveillance.
- Explains that chemotherapy administration is performed on men who do not respond to prostate cancer treatment or hormone therapy as it plays a limited role. radical prostatectomy removes the entire prostate gland and seminal vesicles.
- Concludes that the book provides an insight on prostate cancer and to guide urologists and patients on the right diagnosis.
- Explains that the prostate cancer treatment book provides an insight on the challenging characteristics of the disease, its biotechnological assessments on going researches, technology involving recombination, and future expected medical breakthrough disease treatment.
- Explains that the book focuses on the prevention, early detection, and treatment of prostate cancer. it offers expertise information from several specialists who work in top medical institutions and provides answers to frequently asked questions concerning the disease.
- Introduces denis, louis j., and jacob ramon. prostate cancer: with 43 tables; [indexed in current contents and index medicus].
2067 wordsRead More - Benign Prostatic Hyperplasia Research Paperexplanatory essayBenign prostatic hyperplasia is known as a noncancerous overdevelopment of the prostate; it is also called an enlarged prostate. The abbreviation for benign prostatic hyperplasia is, “BPH.” Another term for benign prostatic hyperplasia is benign prostatic hypertrophy but is most commonly known as benign prostatic hyperplasia.
In this essay, the author
- Explains that benign prostatic hyperplasia is a noncancerous overdevelopment of the prostate, also called an enlarged prostate.
- Explains that benign prostatic hyperplasia is closely related to age and a change in sex hormones that causes enlarged prostates.
- Explains how a health care provider can diagnose benign prostatic hyperplasia by using various tests, such as urinalysis, psa blood test, urine flowmetry, cystoscopy, etc.
- Explains that a health care provider would view the size of the prostate, growth of prostate from original size, discomfort, and overall health before treating benign prostatic hyperplasia.
- Explains that alpha blockers are used to relax the muscles in the prostate to make it easier to urinate.
- Explains that benign prostatic hyperplasia is a disease that can only occur in males. the chance of getting the disease increases with age.
- Opines that benign prostatic hyperplasia, which is an overdevelopment of the prostate, is a disease that will most likely impact most males.
- Cites mayo clinic's website on benign prostatic hyperplasia, and national institute of diabetes and digestive and kidney diseases.
789 wordsRead More - Risks of PSA Testingopinion essay...rgery) cause many serious complications and even death. As a result, the USPSF recommends against the use of PSA based screening test for men of all ages. However, the PSA based screening test an associated treatments of early-detected prostate cancers should be applied only to men who may benefit from early detection and related treatments. In addition to decrease complications and improved treatment effectiveness, PCa treatments should be performed at high volume centers for better control and follow up. We can only hope that future advances will provide a screening test that can better predict prognosis as well as diagnosis and will provide modes of treatment that result in less morbidity and decreased mortality rates.
In this essay, the author
- Explains that psa test results are interpreted as: 0-4 ng/ml is normal. between 4 to 10 nm is 25% of developing cancer, and > 10ml is a > 50% risk of cancer.
- Explains that psa blood levels are used to diagnose prostate cancer, evaluate treatment, and evaluate the severity of benign prostatic hyperplasia (bph).
- Explains that one out of every five in 1000 men who are treated surgically will die within one month of the surgery.
- Explains that the american urological association and the acs believe that psa-based screening and early treatment for prostate cancers are still essential for men but recommend they be applied selectively.
- Argues that early detection of prostate cancers offers the best chance of cure. however, the majority of psa detected tumors have the histologic characteristics of clinically important cancer.
- Opines that psa does detect a large number of early cancers, but this may not be good. pca is often slow growing and indolent, although some cases are aggressive and lethal.
- Explains that the uspstf's decision to recommend against screening for pca affects the community as a whole.
- Explains that some subspecialist groups are questioning the uspstf's interpretation of the data. the epidemiology of pca and the psa test provide compelling arguments for its use.
- Argues that the cost effectiveness of psa for population screening and policy issues related to pca treatment create an apparent conflict between the public health perspective and the interest of individual patients and practitioners.
- Explains that npnurse practitioners play an important role in educating men about prostate cancer to provide optimal choices for diagnosis and treatment.
- Opines that nurse practitioners should provide patients with all the information they need to promote an informed decision that supports each patient’s personal values and preferences.
- Opines that pca is a significant health problem in men, despite growing use of psa testing to screen for it, but authorities disagree about its optimal use.
- Opines that more evidence-based research is needed in relation to psa screening to guide patients to make the most informed decision in regards to prostate cancer screening.
- Recommends that psa based screening test and associated treatments of early-detected prostate cancers should be applied only to men who may benefit from early detection.
1594 wordsRead More - Biomarker discovery for Prostate Canceranalytical essayProstate cancer is the second most common cause of world-wide cancer-related death in men after lung cancer (WCRF International), and in Australia, it accounts for 30% of all new cancers in men and 13.4% of all cancer deaths in men (Cancer Australia). Currently, Prostate Specific Antigen (PSA) is the most commonly used serum biomarker for prostate cancer most routinely used by urologists. However, PSA-based screening has been shown to have high false positives and false negatives with low specificity, and it is not able to distinguish well between cancer and benign prostatic hyperplasia or between indolent and aggressive cancers, thus leading to overtreatment, especially unnecessary biopsies (Otero) (Qian). Therefore, there is an urgent need for a new specific biomarker for the early detection of prostate cancer, and effective biomarkers will be able to reduce morality rates and appropriate clinical interventions can be applied.
In this essay, the author
- Explains that prostate cancer is the second most common cause of cancer-related death in men after lung cancer, and that effective biomarkers will reduce morality rates and appropriate clinical interventions can be applied.
- Explains how different approaches have been tested to discover new biomarkers for the detection of prostate cancer, such as pca3 and tmprss2:erg fusion gene.
- Explains the role of spondin-2 as an independent new serum diagnostic biomarker for prostate cancer.
- Argues that future research in the field of biomarker discovery needs validation in regards to the use of cell lines as a model and the proteomic techniques used.
673 wordsRead More - Autoantibodies Testingexplanatory essaysurvival pathways 26. In addition , Cancer cells are affected by ∆Np63 by several mechanisms, one of them is by encouraging the migratory behavior of cancer cells and the other way is by downing the
In this essay, the author
- Explains that immunoglobulins (igs) are structures emitted by plasma cells, last form of differentiated b cells. the basic composition is made of protein and carbohydrate.
- Explains that based on the pathogenic behavior, two types of autoanitbodies can be named.
- Explains enzyme-linked immunosorbent assay (elisa) developed by peter perlmann and eva engvall.
- Explains that indirect elisa uses 96 wells of polystyrene microplate to adsorb the antigens.
- Explains that secondary antibodies are used to attach to the primary antibodies or antigens fc segment.
- Explains that secondary antibodies can have specific affinity to the h, l, or both parts at the same instant.
- Explains that p63 does not function as a tumor suppressor and is rarely mutated in human cancer. however, it functions as an oncogene when overexpressed.
- Explains that autoantibodies are formed against self tissues as aberration of immune response toward its cells. tolerance of selfantigens is established at early life stages; during embryogenesis the process of tolerance is initiated.
- Explains that autoantibodies can be detectable in patients with no clinical symptoms of any autoimmune diseases. diabetes mellitus is a good example for this use.
- Explains that tumor-associated antigens are produced by tumors that make the autoimmune system capable of recognize them as foreign cells.
- Explains that immune response can be triggered by antigenic stimulus. over-expressed genes lead to increased amounts of protein, which can elicit autoimmune responses by overriding thresholds critical for the maintenance of tolerance.
2330 wordsRead More - Loveexplanatory essayBenign prostatic hyperplasia (BPH) is a condition that affects the prostate gland in men. The prostate is a gland found between the bladder (where urine is stored) and the urethra (the tube urine passes through). As men age, the prostate gland slowly grows bigger (or enlarges). As the prostate gets bigger, it may press on the urethra and cause the flow of urine to be slower and less forceful. The word "benign" means the enlargement isn't caused by cancer or infection. The word "hyperplasia" means enlarged.
In this essay, the author
- Explains that this handout provides a general overview on this topic and may not apply to everyone. to find out if it applies to you, talk to your family doctor.
- Explains that permission is granted to print and photocopy this material for non-profit educational purposes, and written permission for all other uses, including electronic uses.
- Explains that love is the answer to the heart. without love there would only be hate in the world.
- Explains that most symptoms of bph start gradually, including difficulty in starting the urine flow or dribbling after urination ends. they may be signs of serious diseases such as a bladder infection or bladder cancer.
- Explains that a rectal exam allows the doctor to feel the size of the prostate gland.
- Explains that surgery is considered the most effective treatment and is used in men with very strong symptoms. surgery is done through the urethra, leaving no scars.
- Explains that finasteride makes the prostate shrink, but it does not help all patients. alpha blockers can help the symptoms of bph.
874 wordsRead More - Biotechnologyexplanatory essay... () The drug that is being tested is called Diferuloylmethane with 500mg of curcumin. The process of this study’s phase 1 clinical trial was a study done over several months. Curcumin was taken once in the morning with an empty stomach. If there was no toxicity, curcumin was taken for three months. The dosage levels were 1, 2, 3, 4, 5, 6 which correlated to 500, 1000, 2000, 4000, 8000, and 12000 mg/day, respectively. Patients would receive regular follow up appointments which included routine physical examination, weekly hemogram, and biweekly blood electrolytes study. Measurement or evaluation of the indicator lesions was done at least every 4 weeks. Tissue samples would be taken before and after the completion of the 3-month treatment. One of the two patients left developed frank malignancies during the treatment period and thus discontinued the use of curcumin.
In this essay, the author
- Explains that recombinant dna is made by a variety of methods, including transformation, phage introduction, and non-bacterial transformation.
- Explains that genetic engineering is one of the more prominent biotechnological uses and applications for such science.
- Explains the difference between biotechnology companies and pharmaceutical companies. biotechnology uses living organisms to make or modify products to improve a number of sectors.
- Explains that drug development can be divided into three phases: the preclinical phase and the investigational new drug process.
- Explains that the company's primary and secondary endpoints are to ensure the safety and dosage of the patients.
1365 wordsRead More - In Vivo Quantitative Phosphoproteomic Profiling Identifies Novel Regulators of Castration Resistant Prostate Cancer Growthexplanatory essayLNCaP xenografts mimic many of the features of human prostate tumors making them a valuable model to study the mechanism of progression to CRPCa (12, 18). In order to obtain an overview of these mechanisms LNCaP xenografts were grown orthotopically in intact and castrated mice. The analysis of tumor growth show that castration resistant LNCaP tumors (CR-LNCaP) proliferate at a higher rate than androgen sensitive tumors (HS-LNCaP) at the time of harvest, 60 days after surgical orthotopic implantation (Figure 1A, B). This mimics the situation with human CRPCa, which proliferate at a higher rate than castration naïve localized tumors. Moreover, immunohistochemical analysis of orthotopically grown tumors show an increased number of Ki67 positive cells confirming an enhanced proliferative rate. Measurements of active caspase 3 by IHC show diminished activity in castration resistant tumors; indicating that both enhanced proliferation and diminished apoptosis contribute to the increased growth rate of tumors in castrated mice (Figure 1C and 1D). Next, we perform a comprehensive quantitative phosphoproteomic profiling using SILAC labeled LNCaP cells as internal, spiked-in controls in all samples analyzed (19) . In order to account for biological variation, 4 individual tumors were analyzed for each experimental group. In parallel, we also performed a genome-wide transcriptomic analysis (Figure 1E).
In this essay, the author
- Explains that lncap xenografts mimic human prostate tumors, which proliferate at a higher rate than castration nave localized crpca. they perform phosphoproteomic profiling using silac labeled cells as internal, spiked-in controls.
- Analyzes the phosphorylation levels of 2782 peptides from a total of 1212 proteins in at least one of the samples.
- Analyzes the phosphoproteomic data of the mapk, mtorc1 pathways, and pak2 and yap1 in cr-lncap tumors.
- Explains that if the pathways identified as regulated in castration resistant cancer by phosphoproteomic analysis are functionally relevant, the transcriptional program of these tumors would reflect changes in mtor, akt, mapk, yap1 and pak2.
- Explains that the differential phosphorylation signaling molecules in castration resistant vs hormone sensitive tumors may be regulated by androgens.
- Explains the role of pak2 and yap1 in the growth of castration resistant prostate cancer.
- Concludes that yap1 and pak2 have overlapping functions in androgen independent prostate cancer cells that may contribute to the growth and spread of castration resistant tumors.
- Explains schroder fh, hugosson j, tammela tl, ciatto s, nelen v, et al. screening and prostate-cancer mortality in a european study.
- Analyzes the trends in prostate cancer incidence and mortality in the five nordic countries.
- Explains crawford's understanding of the epidemiology, natural history, and key pathways involved in prostate cancer.
- Explains taylor bs, schultz n, hieronymus h, gopalan a, xiao y, carver b. integrative genomic profiling of human prostate cancer
- Describes the aspects of imaging in the assessment and follow-up of benign prostatic hyperplasia.
- Explains the mutational landscape of lethal castration-resistant prostate cancer.
- Explains that in vivo amplification of the androgen receptor gene and progression of human prostate cancer.
- Describes the clinical significance of chromosome 8 alterations in high-grade, advanced, non-
- Explains the cell autonomous role of pten in regulating castration-resistant prostate cancer growth.
- Explains that reciprocal feedback regulation of pi3k and androgen receptor signaling in pten-deficient prostate cancer.
- Explains that pten deficiency is fully penetrant for prostate adenocarcinoma in c57bl/6 mice via mtor-dependent growth.
- Explains horoszewicz js, leong ss, kawinski e, karr jp, rosenthal h, chu tm, et al. lncap model of human prostatic carcinoma
- Explains that prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of ar and mtor.
- Describes stone p, richards m, a'hern r, hardy j. fatigue in patients with breast or prostate cancers undergoing radical radiotherapy.
- Explains the expression of basal cell keratins in human prostate cancer metastases and cell lines.
- Explains pelttari lm, nurminen r, gylfe a, aaltonen la, schleutker j, nevanlinna h. screening of finnish rad51c founder mutations
- Explains the early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical t1-t2 prostate cancer.
- Describes thalmann gn, anezinis pe, chang sm, zhau he, kim ee, hopwood vl, et al. androgen-independent cancer progression and bone metastasis in the lncap model of human prostate cancer.
- Explains that multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction.
- Evaluates the sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer.
- Explains that differentially expressed transcripts in neoplastic hepatic nodules and neonatal rat liver were studied by cdna microarray analysis.
- Explains that few fh mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
- Explains the correlation between transrectal ultrasound and histopathology of radical prostatectomy specimens.
- Explains sedelaar, de la rosette, beerlage, wijkstra, and aarnink. transrectal ultrasound imaging of the prostate: review and perspectives of recent developments.
- Explains harvey kf, zhang x, thomas dm. the hippo pathway and human cancer.
- Explains that the small-molecule p21-activated kinase inhibitor pf-3758309 inhibits oncogenic signaling and tumor growth.
- Explains that human prostate cancer blocks the generation of dendritic cells from cd34+ hematopoietic progenitors.
- Explains that genetic and pharmacological disruption of the tead-yap complex suppresses the oncogenic activity of yap.
- Explains that roberts pj and der cj target the raf-mek-erk mitogen-activated protein kinase cascade for the treatment of cancer.
- Explains that dd3(pca3) is a sensitive and specific marker to detect prostate tumors. cancer research. 2002;62(9):2695-8.
- Explains that the deficiency of akt1 is sufficient to suppress tumor development in pten+/- mice.
- Explains the effect of transurethral needle ablation on symptoms of chronic pelvic pain syndrome.
- Explains that cell detachment activates the hippo pathway via cytoskeleton reorganization to induce anoikis.
- Describes d'antonio jm, ma c, monzon fa, pflug br. longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways
- Explains that high stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
- Analyzes the quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues.
- Explains that timp-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells.
- Explains olsen jv, schwartz jc, griep-raming j, nielsen ml, damoc e, denisov e. a dual pressure linear ion trap orbitrap instrument with very high sequencing speed.
- Explains that the phytoestrogen equol stimulates the transcriptional activity of estrogen-related receptor gamma.
- Explains that androgen induction of prostate cancer cell invasion is mediated by ezrin.
- Explains that pharmacological inhibition of yap1 and pak2 may serve to inhibit crpca tumor growth using pre-clinical models.
- Explains that the ndc80 internal loop is required for recruitment of the ska complex to establish end-on microtubule attachment to kinetochores.
1912 wordsRead More